hVIVO (HVO LN)

Analysis

Industrials • United Kingdom

hVIVO is a full-service early-phase Contract Research Organisation (CRO) and a global leader in human challenge trials. The company provides end-to-end clinical development services, specializing in conducting human challenge trials across various infectious and respiratory indications, and offers comprehensive virology and immunology laboratory services under the hLAB brand. It was founded in 1988 and is headquartered in London, United Kingdom.

Refresh

Exchange Announcement • 12 Oct 2026 13:00

Appointment of Chief Financial Officer

Exchange Announcement • 22 Sep 2026 13:00

Board Changes

Exchange Announcement • 15 Sep 2026 13:01

Interim Results

Exchange Announcement • 15 Sep 2026 13:00

Chief Financial Officer Succession

Exchange Announcement • 08 Sep 2026 21:51

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Appointment of Chief Financial Officer

Board Changes

Interim Results

Chief Financial Officer Succession

Holding(s) in Company